Galitzky J - Search Results

1

Endothelin-1 inhibits TNF alpha-induced iNOS expression in 3T3-F442A adipocytes.

Mérial-Kieny C, Lonchampt M, Cogé F, Verwaerde P, Galizzi JP, Boutin JA, Lafontan M, Levens N, Galitzky J, Félétou M. Mérial-Kieny C, et al. Among authors: galitzky j. Br J Pharmacol. 2003 Jul;139(5):935-44. doi: 10.1038/sj.bjp.0705325. Br J Pharmacol. 2003. PMID: 12839867 Free PMC article.

2

Alpha-2 adrenoceptors in lipolysis: alpha 2 antagonists and lipid-mobilizing strategies.

Lafontan M, Berlan M, Galitzky J, Montastruc JL. Lafontan M, et al. Among authors: galitzky j. Am J Clin Nutr. 1992 Jan;55(1 Suppl):219S-227S. doi: 10.1093/ajcn/55.1.219s. Am J Clin Nutr. 1992. PMID: 1345885 Review.

3

Thermogenic and lipolytic effect of yohimbine in the dog.

Galitzky J, Vermorel M, Lafontan M, Montastruc P, Berlan M. Galitzky J, et al. Br J Pharmacol. 1991 Oct;104(2):514-8. doi: 10.1111/j.1476-5381.1991.tb12460.x. Br J Pharmacol. 1991. PMID: 1797315 Free PMC article.

4

New tools for human fat cell alpha-2A adrenoceptor characterization. Identification on membranes and on intact cells using the new antagonist [3H]RX821002.

Galitzky J, Larrouy D, Berlan M, Lafontan M. Galitzky J, et al. J Pharmacol Exp Ther. 1990 Jan;252(1):312-9. J Pharmacol Exp Ther. 1990. PMID: 1967647

5

Selective reduction of alpha 2-adrenergic responsiveness in hamster adipose tissue during prolonged starvation.

Carpéné C, Galitzky J, Saulnier-Blache JS, Lafontan M. Carpéné C, et al. Among authors: galitzky j. Am J Physiol. 1990 Jul;259(1 Pt 1):E80-8. doi: 10.1152/ajpendo.1990.259.1.E80. Am J Physiol. 1990. PMID: 1973602

6

Non-adrenergic sites for imidazolines are not directly involved in the alpha 2-adrenergic antilipolytic effect of UK 14304 in rat adipocytes.

Carpéné C, Galitzky J, Larrouy D, Langin D, Lafontan M. Carpéné C, et al. Among authors: galitzky j. Biochem Pharmacol. 1990 Aug 1;40(3):437-45. doi: 10.1016/0006-2952(90)90541-r. Biochem Pharmacol. 1990. PMID: 1974423

7

Identification of human platelet alpha 2-adrenoceptors with a new antagonist [3H]-RX821002, a 2-methoxy derivative of idazoxan.

Galitzky J, Senard JM, Lafontan M, Stillings M, Montastruc JL, Berlan M. Galitzky J, et al. Br J Pharmacol. 1990 Aug;100(4):862-6. doi: 10.1111/j.1476-5381.1990.tb14105.x. Br J Pharmacol. 1990. PMID: 1976403 Free PMC article.

8

A1 adenosine receptors in the human fat cell: tissue distribution and regulation of radioligand binding.

Larrouy D, Galitzky J, Lafontan M. Larrouy D, et al. Among authors: galitzky j. Eur J Pharmacol. 1991 Feb 25;206(2):139-47. doi: 10.1016/0922-4106(91)90022-a. Eur J Pharmacol. 1991. PMID: 2065717

9

Human fat cell alpha-2 adrenoceptors. I. Functional exploration and pharmacological definition with selected alpha-2 agonists and antagonists.

Galitzky J, Mauriege P, Berlan M, Lafontan M. Galitzky J, et al. J Pharmacol Exp Ther. 1989 May;249(2):583-91. J Pharmacol Exp Ther. 1989. PMID: 2566681

10

Human fat cell alpha-2 adrenoceptors. II. Comparative study of partial and full agonist binding parameters using [3H]clonidine and [3H]UK-14,304.

Galitzky J, Lafontan M, Paris H, Berlan M. Galitzky J, et al. J Pharmacol Exp Ther. 1989 May;249(2):592-600. J Pharmacol Exp Ther. 1989. PMID: 2566682

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters